Brexit Update

As part of our ongoing commitment to our UK customer base, Insulet has implemented a full Brexit contingency plan to ensure uninterrupted supply of the Omnipod® Insulin Management System to all users, after the UK leaves the European Union.

We have adapted our business processes and secured a forward stocking location in England where we will hold and maintain supply for all our UK customers. There will be no change to the ordering process for either healthcare providers or patients.

We have an experienced team in place committed to ensuring continuity of supply for all UK Omnipod® System users, however should you wish to discuss this further, please don’t hesitate to contact us on Omnipod-GB@insulet.com